340 related articles for article (PubMed ID: 19428813)
1. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
[TBL] [Abstract][Full Text] [Related]
2. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Rodrigo R; Cauli O; Gomez-Pinedo U; Agusti A; Hernandez-Rabaza V; Garcia-Verdugo JM; Felipo V
Gastroenterology; 2010 Aug; 139(2):675-84. PubMed ID: 20303348
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts.
Erceg S; Monfort P; Hernández-Viadel M; Rodrigo R; Montoliu C; Felipo V
Hepatology; 2005 Feb; 41(2):299-306. PubMed ID: 15660436
[TBL] [Abstract][Full Text] [Related]
5. Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain.
Erceg S; Monfort P; Hernandez-Viadel M; Llansola M; Montoliu C; Felipo V
Brain Res; 2005 Mar; 1036(1-2):115-21. PubMed ID: 15725408
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.
Cauli O; Rodrigo R; Piedrafita B; Boix J; Felipo V
Hepatology; 2007 Aug; 46(2):514-9. PubMed ID: 17659565
[TBL] [Abstract][Full Text] [Related]
7. Treatment with sildenafil prevents impairment of learning in rats born to pre-eclamptic mothers.
Cauli O; Herraiz S; Pellicer B; Pellicer A; Felipo V
Neuroscience; 2010 Dec; 171(2):506-12. PubMed ID: 20832451
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
[TBL] [Abstract][Full Text] [Related]
9. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure.
Rodrigo R; Erceg S; Rodriguez-Diaz J; Saez-Valero J; Piedrafita B; Suarez I; Felipo V
J Neurochem; 2007 Jul; 102(1):51-64. PubMed ID: 17286583
[TBL] [Abstract][Full Text] [Related]
10. Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex.
Cauli O; Mansouri MT; Agusti A; Felipo V
Gastroenterology; 2009 Apr; 136(4):1359-67, e1-2. PubMed ID: 19245864
[TBL] [Abstract][Full Text] [Related]
11. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.
Agusti A; Cauli O; Rodrigo R; Llansola M; Hernández-Rabaza V; Felipo V
Gut; 2011 Nov; 60(11):1572-9. PubMed ID: 21636647
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo.
González-Usano A; Cauli O; Agustí A; Felipo V
J Neurochem; 2013 Apr; 125(1):133-43. PubMed ID: 23227932
[TBL] [Abstract][Full Text] [Related]
13. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity.
Cauli O; Rodrigo R; Piedrafita B; Llansola M; Mansouri MT; Felipo V
J Neurosci Res; 2009 May; 87(6):1369-74. PubMed ID: 19025766
[TBL] [Abstract][Full Text] [Related]
15. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
Rodrigo R; Felipo V
Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
[TBL] [Abstract][Full Text] [Related]
16. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
Felipo V
World J Gastroenterol; 2006 Dec; 12(48):7737-43. PubMed ID: 17203513
[TBL] [Abstract][Full Text] [Related]
17. Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum.
ElMlili N; Boix J; Ahabrach H; Rodrigo R; Errami M; Felipo V
J Neurochem; 2010 Feb; 112(4):1005-14. PubMed ID: 20002515
[TBL] [Abstract][Full Text] [Related]
18. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats.
Aguilar MA; Miñarro J; Felipo V
Exp Neurol; 2000 Feb; 161(2):704-13. PubMed ID: 10686089
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptors in hyperammonemia and hepatic encephalopathy.
Llansola M; Rodrigo R; Monfort P; Montoliu C; Kosenko E; Cauli O; Piedrafita B; El Mlili N; Felipo V
Metab Brain Dis; 2007 Dec; 22(3-4):321-35. PubMed ID: 17701332
[TBL] [Abstract][Full Text] [Related]
20. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
